Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Quantifying Blood Flow in the Aorta (AF-4DMRI-P2)

4. mai 2026 oppdatert av: Marleen Krommendijk, University of Twente

Quantifying Blood Flow in the Aorta Using Phase-Contrast 4D Flow MRI - Phase 2

This study aims to gain insights into aortic blood flow in healthy volunteers using PC 4D-flow MRI

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

The goal of this observational study is to obtain PC 4D flow MRI scans in seventy healthy volunteers (without any known history of cardiovascular disease) to quantify local blood flow in the thoraco-abdominal aorta and its primary side branches and extract boundary conditions for future in-vitro and in-silico studies. Furthermore, the 3D geometry of the vessels within investigated FOVs, starting from ascending aorta to internal/external iliac arteries, will be obtained by performing a separate MRI sequence.

Participants will be asked to undergo MRI scans and are asked to fill out a questionnaire regarding their age, weight, height, and gender. By relating this data to the blood flow patterns observed in the aorta, conclusions can be drawn on the differences in blood flow with gender and how aortic blood flow changes with age.

Studietype

Observasjonsmessig

Registrering (Antatt)

70

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

  • Nederland
    • Overijssel
      • Enschede, Overijssel, Nederland, 7522 NH
        • Rekruttering
        • TechMed centre, University of Twente
        • Ta kontakt med:
        • Underetterforsker:
          • Hadi Mirgolbabaee, dr.
        • Underetterforsker:
          • Marleen E. Krommendijk, ir.

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Healthy subjects with no known cardiovascular disease or history thereof

Beskrivelse

Inclusion Criteria:

  • Healthy (in particular without any cardiovascular disease or history thereof) men or women
  • 18 years of age or above;
  • BMI ≤ 30;
  • Willingness to undergo MRI scans;
  • Able to provide signed informed consent (IC)

Exclusion Criteria:

  • Irregular heartbeat.;
  • Any history of cardiovascular disease or current cardiovascular disease;
  • The standard MRI exclusion criteria (such as pacemakers, cerebral vascular clips, pregnancy, claustrophobia)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Group 1
Five men aged 18-25 and five women aged 18-25
Annen: 4D-flow Magnetic Resonance Imaging
Subjects will undergo MRI scans of the thorax and abdomen from which we will derive aortic blood flow velocity fields. This intervention will be performed in the same manner on all groups.
Andre navn:
  • Magnetisk resonansavbildning
  • Phase contrast MRI
  • PC-MRI
Annen: Questionnaires
Subjects fill in a questionnaire regarding their weight, height, age and gender. They also fill in a safety check form to test if MRI can be applied safely.
Group 2
Five men aged 26-35 and five women aged 26-35
Annen: 4D-flow Magnetic Resonance Imaging
Subjects will undergo MRI scans of the thorax and abdomen from which we will derive aortic blood flow velocity fields. This intervention will be performed in the same manner on all groups.
Andre navn:
  • Magnetisk resonansavbildning
  • Phase contrast MRI
  • PC-MRI
Annen: Questionnaires
Subjects fill in a questionnaire regarding their weight, height, age and gender. They also fill in a safety check form to test if MRI can be applied safely.
Group 3
Five men aged 36-45 and five women aged 36-45
Annen: 4D-flow Magnetic Resonance Imaging
Subjects will undergo MRI scans of the thorax and abdomen from which we will derive aortic blood flow velocity fields. This intervention will be performed in the same manner on all groups.
Andre navn:
  • Magnetisk resonansavbildning
  • Phase contrast MRI
  • PC-MRI
Annen: Questionnaires
Subjects fill in a questionnaire regarding their weight, height, age and gender. They also fill in a safety check form to test if MRI can be applied safely.
Group 4
Five men aged 46-55 and five women aged 46-55
Annen: 4D-flow Magnetic Resonance Imaging
Subjects will undergo MRI scans of the thorax and abdomen from which we will derive aortic blood flow velocity fields. This intervention will be performed in the same manner on all groups.
Andre navn:
  • Magnetisk resonansavbildning
  • Phase contrast MRI
  • PC-MRI
Annen: Questionnaires
Subjects fill in a questionnaire regarding their weight, height, age and gender. They also fill in a safety check form to test if MRI can be applied safely.
Group 5
Five men aged 56-65 and five women aged 56-65
Annen: 4D-flow Magnetic Resonance Imaging
Subjects will undergo MRI scans of the thorax and abdomen from which we will derive aortic blood flow velocity fields. This intervention will be performed in the same manner on all groups.
Andre navn:
  • Magnetisk resonansavbildning
  • Phase contrast MRI
  • PC-MRI
Annen: Questionnaires
Subjects fill in a questionnaire regarding their weight, height, age and gender. They also fill in a safety check form to test if MRI can be applied safely.
Group 6
Five men aged 66-75 and five women aged 66-75
Annen: 4D-flow Magnetic Resonance Imaging
Subjects will undergo MRI scans of the thorax and abdomen from which we will derive aortic blood flow velocity fields. This intervention will be performed in the same manner on all groups.
Andre navn:
  • Magnetisk resonansavbildning
  • Phase contrast MRI
  • PC-MRI
Annen: Questionnaires
Subjects fill in a questionnaire regarding their weight, height, age and gender. They also fill in a safety check form to test if MRI can be applied safely.
Group 7
Five men aged 76-85 and five women aged 76-85
Annen: 4D-flow Magnetic Resonance Imaging
Subjects will undergo MRI scans of the thorax and abdomen from which we will derive aortic blood flow velocity fields. This intervention will be performed in the same manner on all groups.
Andre navn:
  • Magnetisk resonansavbildning
  • Phase contrast MRI
  • PC-MRI
Annen: Questionnaires
Subjects fill in a questionnaire regarding their weight, height, age and gender. They also fill in a safety check form to test if MRI can be applied safely.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Aortic blood flow velocity fields
Tidsramme: Day 1
Velocity fields will be acquired, consisting of vectors that describe the velocity magnitude (cm/s) and direction (dimensionless) of blood flow in the aorta. For visualisation purposes, arrows will be used to overlay the shape of the volunteers aorta. Colours of the arrrows indicate the velocity magnitude and direction of the arrows inicate the direction of flow. Velocity fields are generated for the the full aorta, from the ascending aorta to internal/external iliac arteries, including branched arteries such as subclavian arteries, common carotid artery, and visceral branch vessels.
Day 1

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Age of volunteer
Tidsramme: Day 1
Age of volunteer (in years) for division into groups based on gender and age, gathered using a questionnaire.
Day 1
Gender of volunteer
Tidsramme: Day 1
Gender of volunteer (male/female/other) for division into groups based on gender and age, gathered using a questionnaire.
Day 1
Height of volunteer
Tidsramme: Day 1
Height (in m) for BMI (in kg/m^2) calculation, gathered using a questionnaire.
Day 1
Weight of volunteer
Tidsramme: Day 1
Weight (in kg) for BMI (in kg/m^2) calculation, gathered using a questionnaire.
Day 1
Aortic blood flow waveforms
Tidsramme: Day 1
Waveforms will be acquired that show how aortic blood flow in a certain region of interest progresses over the cardiac cycle, presented as plots of velocity magnitude (cm/s) over time (s). Regions of interest are selected in the ascending aorta, descending aorta, carotid arteries, subclavian arteries, renal arteries, suprarenal aorta, abdominal aorta, common iliac arteries, internal iliac arteries, and external iliac arteries.
Day 1
Wall shear stress
Tidsramme: Day 1
Wall shear stress (Pa) is a hemodynamic parameter expressing the force acting on a certain area of the vessel wall by the flow of blood. This parameter will be extracted from the blood flow velocity vectors in a certain region of interest (e.g. in the ascending aorta, descending aorta, renal arteries, or iliac arteries) and will be plotted over the cardiac cycle.
Day 1
Oscillatory Shear Index
Tidsramme: Day 1
Oscillatory Shear Index (dimensionless) is a hemodynamic parameter that defines how much the wall shear stress field changes directions over time, which can tell something about whether the forces on the wall (and the flow of blood) are more uniform or more complex. This parameter will be extracted from the blood flow velocity vectors in a certain region of interest (e.g. in the ascending aorta, descending aorta, renal arteries, or iliac arteries) and will be plotted over the cardiac cycle.
Day 1
Kinetic Energy
Tidsramme: Day 1
Kinetic Energy (J) in the field of fluid mechanics describes the energy related to the flow of blood in a certain region of interest with a certain mass or volume. This parameter will be extracted from the blood flow velocity vectors in a certain region of interest (e.g. in the ascending aorta, descending aorta, renal arteries, or iliac arteries) and will be plotted over the cardiac cycle.
Day 1
Turbulent Kinetic Energy
Tidsramme: Day 1
Turbulent Kinetic Energy (J/kg) is a hemodynamic parameter describing the energy related to the fluctuations in blood flow velocity. This parameter will be extracted from the blood flow velocity vectors in a certain region of interest (e.g. in the ascending aorta, descending aorta, renal arteries, or iliac arteries) and will be plotted over the cardiac cycle.
Day 1
Helicity
Tidsramme: Day 1
Helicity (m^4/s^2) is a hemodynamic parameter that describes how much the blood flow follows a corkscrew-like pattern. This parameter will be extracted from the blood flow velocity vectors in a certain region of interest (e.g. in the ascending aorta, descending aorta, renal arteries, or iliac arteries) and will be plotted over the cardiac cycle.
Day 1
Vorticity
Tidsramme: Day 1
Vorticity (s^-1) is a hemodynamic parameter that reflects the rotational nature of the blood flow. This parameter will be extracted from the blood flow velocity vectors in a certain region of interest (e.g. in the ascending aorta, descending aorta, renal arteries, or iliac arteries) and will be plotted over the cardiac cycle.
Day 1

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

University of Twente

Etterforskere

  • Hovedetterforsker: Michel M.P.J. Reijnen, prof. dr., University of Twente

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. juni 2026

Primær fullføring (Antatt)

31. juli 2026

Studiet fullført (Antatt)

31. juli 2027

Datoer for studieregistrering

Først innsendt

17. mars 2026

Først innsendt som oppfylte QC-kriteriene

4. mai 2026

Først lagt ut (Faktiske)

11. mai 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

11. mai 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

4. mai 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • AF-4DMRI-P2
  • NL88490.091.25 (Annen identifikator: Centrale Commissie Mensgebonden Onderzoek (CCMO))

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på 4D-flow Magnetic Resonance Imaging

Søk i lignende forsøk

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

CROs by country

CROs in Nigeria

Forhold

Sjeldne sykdommer

Legemiddelintervensjoner

Kosttilskudd

Sponsor / samarbeidspartnere

Steder

Abonnere